Regulatory guidelines and existing protocols to govern aspects of mRNA quality during development and manufacturing are still evolving, creating a lack of clarity and consensus amongst the mRNA community.
Reuniting industry experts in quality control, quality assurance, analytical development, and CMC, this forum aims to navigate regulatory guidelines and identify tangible best practices towards optimized documentation, discuss verification processes for platform methods and review method validation used to evaluate critical vaccine qualities, all towards safeguarding faster mRNA drug approvals in line with regulatory expectations.
Download the free brochure or book your place now, early birds are still available!